Skip to main content
. Author manuscript; available in PMC: 2017 Oct 28.
Published in final edited form as: J Nat Prod. 2016 Oct 13;79(10):2731–2739. doi: 10.1021/acs.jnatprod.6b00742

Table 4.

Viability of PC3 (prostate), A549 (lung) human cancer cell lines at 10 μM treatment for 15, actinomycins Y1 and D after 48 h.

Compounds EC50 (nM)
PC3 Cells A549 Cells
1 76.70 71.48
2 51.18 119.30
3 2.77 7.67
4 0.47 1.54
5 0.16 0.74
Y1 0.319 0.135
D 0.276 0.201